The objective of the present study was to investigate the abundance of CD47 molecule in multiple histological subtypes of STS to deeper understand the pathogenesis of these rare diseases and to guide the future therapeutic modalities for the treatment of patients with STS. Here, CD47 is linked to telomere syndrome.